Tag Archives: Myeloid

Potential for new therapies to target acute myeloid leukaemia

Eight people are diagnosed with acute myeloid leukaemia in the UK each day, accounting for over 2000 deaths each year. But a new potential therapeutic target has been uncovered, which could help improve future treatments. Scientists from Cardiff University have identified a biological molecule, Gata2, which could provide new avenues for developing effective therapies for… Read More »

FDA Approves Daurismo (glasdegib) for Patients with Acute Myeloid Leukemia

FDA Approves Daurismo (glasdegib) for Patients with Acute Myeloid Leukemia Print this page November 21, 2018 — The U.S. Food and Drug Administration today approved Daurismo (glasdegib) tablets to be used in combination with low-dose cytarabine (LDAC), a type of chemotherapy, for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adults who are 75… Read More »